PAVmed Inc.
PAVM
$9.11
-$0.22-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.00K | 29.00K | 1.02M | 1.99M | 3.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.00K | 29.00K | 1.02M | 1.99M | 3.00M |
| Cost of Revenue | 217.00K | 180.00K | 1.51M | 3.13M | 4.84M |
| Gross Profit | -146.00K | -151.00K | -486.00K | -1.14M | -1.84M |
| SG&A Expenses | 17.17M | 16.57M | 22.43M | 29.79M | 36.15M |
| Depreciation & Amortization | -- | 0.00 | 82.00K | 187.00K | 559.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.88M | 20.22M | 27.95M | 37.89M | 47.48M |
| Operating Income | -21.81M | -20.19M | -26.93M | -35.90M | -44.49M |
| Income Before Tax | -2.47M | 1.43M | 68.15M | 65.56M | 28.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.47 | 1.43 | 68.15 | 65.56 | 28.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.87M | 1.67M | 4.73M | 8.41M | 11.36M |
| Net Income | 401.00K | 3.10M | 72.88M | 73.97M | 39.79M |
| EBIT | -21.81M | -20.19M | -26.93M | -35.90M | -44.49M |
| EBITDA | -21.70M | -20.04M | -26.55M | -35.24M | -43.29M |
| EPS Basic | 7.83 | 11.10 | 212.75 | 199.08 | 82.20 |
| Normalized Basic EPS | -3.60 | -6.20 | -14.96 | -28.53 | -44.96 |
| EPS Diluted | -24.88 | -21.17 | 30.91 | 17.36 | -71.47 |
| Normalized Diluted EPS | -1.89 | -2.15 | -3.76 | -17.33 | -35.48 |
| Average Basic Shares Outstanding | 2.68M | 2.14M | 1.76M | 1.46M | 1.29M |
| Average Diluted Shares Outstanding | 3.97M | 7.47M | 8.23M | 7.93M | 6.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |